Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ingeborg Fraunholz
High Survivin Expression as a Risk Factor in Patients With Anal Carcinoma Treated With Concurrent Chemoradiotherapy
Radiation Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Clinical Efficacy and Prognostic Factors in Locally Advanced Cervical Cancer Patients Treated With Concurrent Chemoradiotherapy
Med One
A Prospective Study to Assess Prognostic Factors for Patients With Cervical Cancer Stage II Treated With Concurrent Chemoradiotherapy
Journal of Medical Science And clinical Research
Comparison Between Late‑course Accelerated Hyperfractionation Radiotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Carcinoma
Oncology Letters
Cancer Research
Oncology
Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy
Frontiers in Oncology
Cancer Research
Oncology
Role of Autophagy-Related Protein Expression in Patients With Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Chemoradiotherapy With Capecitabine for Locally Advanced Anal Carcinoma: An Alternative Treatment Option
British Journal of Cancer
Cancer Research
Oncology
P2.17-25 Post-Treatment Neutrophil to Lymphocyte Ratio in Locally Advanced NSCLC Patients Treated With Concurrent Chemoradiotherapy
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Immune Inflammation Indicators in Anal Cancer Patients Treated With Concurrent Chemoradiation: Training and Validation Cohort With Online Calculator (ARC: Anal Cancer Response Classifier) [Corrigendum]
Cancer Management and Research
Oncology
The Effect of Adjuvant Chemotherapy on Survival in Patients With Residual Nasopharyngeal Carcinoma After Undergoing Concurrent Chemoradiotherapy
PLoS ONE
Multidisciplinary
